FDA's counsel accused of being too close to drug industry
AUTOR(ES)
Lenzer, Jeanne
FONTE
BMJ Publishing Group Ltd.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=487725Documentos Relacionados
- FDA's approval of anesthetic challenged following deaths
- FDA's safety reform is greeted with scepticism
- New law aims to distance the FDA from the drug industry
- NICE is told to break its close links with drug industry
- Fast tracking drugs to patients: Drug approval agencies are frequently criticised for either being too slow or too fast